Commentary: Bleeding Ulcers, Interaction Between NSAIDs and Helicobacter pylori Infection, and Nonulcer Dyspepsia

https://doi.org/10.1016/S0016-5085(97)80019-4Get rights and content

First page preview

First page preview
Click to open first page preview

References (32)

  • DM Jensen et al.

    The prevalence of H. pylori and NSAID use in patients with severe UGI hemorrhage and their potential role in recurrence of ulcer bleeding (abstr)

    Gastroenterology

    (1992)
  • KC Lai et al.

    Bleeding ulcers have high false-negative rates for antral H. pylori when tested with urease test (abstr)

    Gastroenterology

    (1996)
  • DY Graham et al.

    Treatment of H. pylori reduces the rate of rebleeding in peptic ulcer disease

    Scand J Gastroenterol

    (1993)
  • J Labenz et al.

    Role of H. pylori eradication in the prevention of peptic ulcer bleeding relapse

    Digestion

    (1994)
  • DM Jensen et al.

    A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer

    N Engl J Med

    (1994)
  • JY Sung et al.

    H. pylori eradication or maintenance H2-blockade in preventing recurrent ulcer bleeding (abstr)

    Gastroenterology

    (1996)
  • Cited by (7)

    View all citing articles on Scopus
    b

    Dr. Veldhuyzen van Zanten holds a Career Award from the Pharmaceutical Manufacturers Association of Canada/Medical Research Council.

    c

    Dr. Veldhuyzen van Zanten has been involved in clinical studies sponsored by Abbot Laboratories, Alimenterics, Astra Pharma, Axcan, Glaxo Wellcome, and Tap Pharmaceuticals and has written a teaching program for Janssen and a Website page for Astra. No conflict of interest exists with the content of this article, and no financial endorsement was received for writing it.

    View full text